Life Sciences Group Capabilities

With Tiberend Strategic Advisors, Inc. your company has an edge over the competition. Using a combination of industry insights from our high-profile members of the Tiberend Advisory Board for Science, Business & Technology, propriety databases and proven financial communications strategies, TSAI Life Sciences Group keeps our clients up to date on scientific and investor conferences and media opportunities to position each company as a smart and attractive investment. 

Clients take advantage of our invaluable media relationships to ensure they are included alongside peers and big industry players in definitive, trendsetting business and trade media articles.

By implementing a strategic communications strategy and educating reporters about client strategy, programs, clinical data, financing, partnering and commercialization news, TSAI can enhance the investment community’s perception of your company. Our carefully honed personalized approach has assisted clinical-stage private, micro and small-cap biotechnology companies increase their visibility among investors and peers and often plays a key role in securing financing, drug partnering, acquisitions, licensing and pre-IPO media.